chr5-36051902-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_174914.4(UGT3A2):c.279T>A(p.Phe93Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000414 in 1,595,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_174914.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UGT3A2 | NM_174914.4 | c.279T>A | p.Phe93Leu | missense_variant | 3/7 | ENST00000282507.8 | NP_777574.2 | |
UGT3A2 | NM_001168316.2 | c.177T>A | p.Phe59Leu | missense_variant | 2/6 | NP_001161788.1 | ||
UGT3A2 | XM_011513988.2 | c.360T>A | p.Phe120Leu | missense_variant | 4/8 | XP_011512290.1 | ||
UGT3A2 | NR_031764.2 | n.372T>A | non_coding_transcript_exon_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UGT3A2 | ENST00000282507.8 | c.279T>A | p.Phe93Leu | missense_variant | 3/7 | 1 | NM_174914.4 | ENSP00000282507 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000288 AC: 67AN: 232374Hom.: 0 AF XY: 0.000254 AC XY: 32AN XY: 125976
GnomAD4 exome AF: 0.000419 AC: 605AN: 1442750Hom.: 0 Cov.: 30 AF XY: 0.000374 AC XY: 268AN XY: 717354
GnomAD4 genome AF: 0.000368 AC: 56AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2022 | The c.279T>A (p.F93L) alteration is located in exon 3 (coding exon 3) of the UGT3A2 gene. This alteration results from a T to A substitution at nucleotide position 279, causing the phenylalanine (F) at amino acid position 93 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at